InflaRx N.V. (IFRX) vs Utah Medical Products, Inc. (UTMD)
A side-by-side comparison of InflaRx N.V. and Utah Medical Products, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IFRX
InflaRx N.V.
$1.60HealthcareDelayed quote: Oct 6, 2026, 2:24 PM EDT
UTMD
Utah Medical Products, Inc.
$74.11HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — IFRX vs UTMD
growth of $100 · dividends reinvested · last 9yIFRX -88.8% (-21.6%/yr)UTMD +10.2% (+1.1%/yr)UTMD compounded faster over this window
Log scale — wide-divergence pair
IFRX UTMD
IFRX vs UTMD: by the numbers
- •UTMD is the larger company ($236M vs $235M market cap).
- •UTMD is profitable (29.04% net margin) while IFRX runs a net loss (-155582.08%).
- •UTMD pays a dividend (1.67% yield), while IFRX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | IFRX | UTMD |
|---|---|---|
| P/E ratio | N/A | 22.59 |
| PEG ratio | N/A | 6.59 |
| P/S ratio | N/A | 6.54 |
| P/B ratio | 1.41 | 1.93 |
| EV / EBITDA | N/A | 18.61 |
| FCF yield | N/A | 4.85% |
Profitability
| Metric | IFRX | UTMD |
|---|---|---|
| Gross margin | -24677.94% | 54.88% |
| Operating margin | -164525.50% | 28.46% |
| Net margin | -155582.08% | 29.04% |
| ROE | -27.27% | 8.59% |
| ROIC | -25.38% | 6.83% |
Dividends
| Metric | IFRX | UTMD |
|---|---|---|
| Dividend yield | N/A | 1.67% |
| Payout ratio | N/A | 37.80% |
Growth (annualized)
| Metric | IFRX | UTMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.75% |
| EPS CAGR (5Y) | N/A | 3.36% |
| FCF CAGR (5Y) | N/A | -11.12% |
| Total return CAGR (5Y) | -7.34% | -2.70% |
Frequently asked
- Does IFRX or UTMD pay a bigger dividend?
- UTMD pays a dividend (1.67% yield), while IFRX has no payments in the available dividend history.
- Is IFRX or UTMD more profitable?
- UTMD runs the higher net margin — IFRX at -155582.08% versus UTMD at 29.04%.
- How have IFRX and UTMD total returns compared?
- Over the past 5 years, IFRX delivered -7.34% and UTMD delivered -2.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Utah Medical Products P/E ratioUtah Medical Products dividend yieldInflaRx ROEUtah Medical Products ROEInflaRx operating marginUtah Medical Products operating marginInflaRx revenue growthUtah Medical Products revenue growthInflaRx free cash flowUtah Medical Products free cash flow
InflaRx & Utah Medical Products appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.